{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:03:45Z","timestamp":1761505425362,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2000,4]]},"DOI":"10.3816\/clc.2000.s.005","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T21:04:21Z","timestamp":1221167061000},"page":"S24-S26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S1","title":["Trials of Vinorelbine and Docetaxel in the Treatment of Advanced Non\u2013Small-Cell Lung Cancer"],"prefix":"10.3816","volume":"1","author":[{"given":"Vincent A.","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLC.2000.s.005_bib1","series-title":"Lung Cancer","first-page":"217","article-title":"New chemotherapeutic agents in NSCLC","author":"Miller","year":"1998"},{"key":"10.3816\/CLC.2000.s.005_bib2","first-page":"299","article-title":"In vitro combination effect of docetaxel (RP56976) with vinca alkaloids on cancer cell lines","volume":"36","author":"Hino","year":"1995","journal-title":"Proc Am Assoc Cancer Res"},{"key":"10.3816\/CLC.2000.s.005_bib3","first-page":"291","article-title":"Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines","volume":"19","author":"Aoe","year":"1999","journal-title":"Anticancer Res"},{"key":"10.3816\/CLC.2000.s.005_bib4","first-page":"489a","article-title":"Preclinical in vivo activity of docetaxel-containing combinations","volume":"14","author":"Bissery","year":"1995","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CLC.2000.s.005_bib5","first-page":"229","article-title":"Bcl2 is the guardian of microtubule integrity","volume":"57","author":"Haldar","year":"1997","journal-title":"Cancer Res"},{"issue":"6 Suppl 6","key":"10.3816\/CLC.2000.s.005_bib6","first-page":"29","article-title":"Docetaxel combined with vinorelbine: phase I results and new study designs","volume":"11","author":"Fumoleau","year":"1997","journal-title":"Oncology (Huntingt)"},{"key":"10.3816\/CLC.2000.s.005_bib7","first-page":"481a","article-title":"Phase I trial of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer previously treated with platinumbased chemotherapy","volume":"16","author":"Schiller","year":"1997","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CLC.2000.s.005_bib8","first-page":"15","article-title":"Docetaxel (Taxotere) and vinorelbine in the treatment of advanced nonsmall cell lung cancer: preliminary results of a phase I\/II trial","volume":"24","author":"Miller","year":"1997","journal-title":"Semin Oncol"},{"key":"10.3816\/CLC.2000.s.005_bib9","first-page":"509a","article-title":"Phase I\/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer (NSCLC) previously treated with platinumbased chemotherapy","volume":"18","author":"Hotton","year":"1999","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CLC.2000.s.005_bib10","first-page":"476a","article-title":"Phase I trial of weekly docetaxel (D) and vinorelbine (V) in advanced non-small cell lung cancer (NSCLC)","volume":"18","author":"Johnston","year":"1999","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CLC.2000.s.005_bib11","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2083::AID-CNCR6>3.0.CO;2-I","article-title":"First-line treatment of advanced non small cell lung carcinoma with docetaxel and vinorelbine","volume":"83","author":"Kourousis","year":"1998","journal-title":"Cancer"},{"issue":"Suppl","key":"10.3816\/CLC.2000.s.005_bib12","first-page":"95","article-title":"Interim results of a phase II study of docetaxel (Taxotere) and vinorelbine in chemotherapy naive patients with advanced non small cell lung carcinoma (NSCLC)","volume":"7","author":"Trillet-Lenoir","year":"1996","journal-title":"Annals of Oncology"},{"key":"10.3816\/CLC.2000.s.005_bib13","first-page":"460a","article-title":"Phase II trial of dose dense docetaxel plus vinorelbine with prophylactic filgrastim (G-CSF) in advanced non-small cell lung cancer (NSCLC)","volume":"18","author":"Krug","year":"1999","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CLC.2000.s.005_bib14","first-page":"463a","article-title":"A phase II study of sequence-dependent docetaxel (D)\/vinorelbine (V) DNA damage-induced apoptosis in patients with non-small cell lung cancer (NSCLC)","volume":"18","author":"Balana","year":"1999","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730411706076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730411706076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:01:05Z","timestamp":1761505265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730411706076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":14,"alternative-id":["S1525730411706076"],"URL":"https:\/\/doi.org\/10.3816\/clc.2000.s.005","relation":{},"ISSN":["1525-7304"],"issn-type":[{"type":"print","value":"1525-7304"}],"subject":[],"published":{"date-parts":[[2000,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trials of Vinorelbine and Docetaxel in the Treatment of Advanced Non\u2013Small-Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CLC.2000.s.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}